Dashboard
Manage Tickers

IPSC Century Therapeutics, Inc.

Nasdaq centurytx.com


$ 0.47 $ 0.01 (1.68 %)    

Friday, 14-Nov-2025 15:47:42 EST
CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ $ 608.45 $ 0.46 (0.08 %)
DIA $ 471.65 $ -2.94 (-0.62 %)
SPY $ 671.62 $ -0.11 (-0.02 %)
TLT $ 88.93 $ -0.51 (-0.57 %)
GLD $ 375.82 $ -6.91 (-1.8 %)
$ 0.4723
$ 0.48
$ 0.47 x 2,282
$ 0.47 x 1,000
$ 0.46 - $ 0.48
$ 0.34 - $ 1.83
990,181
na
41.24M
$ 1.36
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-15-2025 03-31-2025 10-Q
4 03-19-2025 12-31-2024 10-K
5 11-05-2024 09-30-2024 10-Q
6 08-08-2024 06-30-2024 10-Q
7 05-09-2024 03-31-2024 10-Q
8 03-14-2024 12-31-2023 10-K
9 11-09-2023 09-30-2023 10-Q
10 08-09-2023 06-30-2023 10-Q
11 05-11-2023 03-31-2023 10-Q
12 03-16-2023 12-31-2022 10-K
13 11-10-2022 09-30-2022 10-Q
14 08-11-2022 06-30-2022 10-Q
15 05-16-2022 03-31-2022 10-Q
16 03-17-2022 12-31-2021 10-K
17 11-10-2021 09-30-2021 10-Q
18 08-12-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

century-therapeutics-q3-eps-040-misses-034-estimate
Century Therapeutics Q3 EPS $(0.40) Misses...
11/13/2025 12:34:23

Century Therapeutics (NASDAQ:IPSC) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate o...

century-therapeutics-launches-allo-evasion-50-ipsc-beta-islet-program-for-type-1-diabetes-with-preclinical-data-showing-rapid-diabetes-reversal-and-plans-ind-enabling-studies-by-year-end-2025
Century Therapeutics Launches Allo-Evasion...
11/13/2025 12:26:27

century-therapeuics-appoints-brent-pfeiffenberger-as-chairman
Century Therapeuics Appoints Brent Pfeiffe...
08/14/2025 20:59:57

century-therapeutics-q2-eps-038-misses-037-estimate
Century Therapeutics Q2 EPS $(0.38) Misses...
08/14/2025 20:26:03

century-therapeutics-files-for-mixed-shelf-offering-of-up-to-200m
Century Therapeutics Files For Mixed Shelf...
07/10/2025 20:58:30

- SEC Filing

chardan-capital-maintains-buy-on-century-therapeutics-lowers-price-target-to-6
Chardan Capital Maintains Buy on Century T...
05/16/2025 22:33:52

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

century-therapeutics-q1-eps-089-beats-016-estimate-sales-10916m-beat-4955m-estimate
Century Therapeutics Q1 EPS $0.89 Beats $0...
05/15/2025 20:16:26

Century Therapeutics (NASDAQ:IPSC) reported quarterly earnings of $0.89 per share which beat the analyst consensus estimate of ...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
04/16/2025 12:07:22

hc-wainwright--co-maintains-buy-on-century-therapeutics-lowers-price-target-to-2
HC Wainwright & Co. Maintains Buy on Centu...
04/03/2025 10:59:41

HC Wainwright & Co. analyst Mitchell Kapoor maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price...

12-health-care-stocks-moving-in-fridays-after-market-session
12 Health Care Stocks Moving In Friday's A...
03/28/2025 21:05:46

guggenheim-reiterates-buy-on-century-therapeuticsto-buy
Guggenheim Reiterates Buy on Century Thera...
03/28/2025 14:43:23

Guggenheim analyst Kelsey Goodwin reiterates Century Therapeutics (NASDAQ:IPSC) from Buy to Buy.

carnival-to-rally-around-48-here-are-10-top-analyst-forecasts-for-monday
Carnival To Rally Around 48%? Here Are 10 ...
03/24/2025 12:48:18

chardan-capital-maintains-buy-on-century-therapeutics-lowers-price-target-to-7
Chardan Capital Maintains Buy on Century T...
03/24/2025 12:07:01

Chardan Capital analyst Geulah Livshits maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target ...

demystifying-century-therapeutics-insights-from-4-analyst-reviews
Demystifying Century Therapeutics: Insight...
03/21/2025 14:01:08

guggenheim-maintains-buy-on-century-therapeutics-lowers-price-target-to-5
Guggenheim Maintains Buy on Century Therap...
03/21/2025 13:55:07

Guggenheim analyst Kelsey Goodwin maintains Century Therapeutics (NASDAQ:IPSC) with a Buy and lowers the price target from $...

piper-sandler-maintains-overweight-on-century-therapeutics-lowers-price-target-to-2
Piper Sandler Maintains Overweight on Cent...
03/20/2025 16:37:49

Piper Sandler analyst Edward Tenthoff maintains Century Therapeutics (NASDAQ:IPSC) with a Overweight and lowers the price ta...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
03/19/2025 21:06:24

century-therapeutics-fy24-eps-161-up-from-230-yoy-revenue-659m-up-from-224m-yoy
Century Therapeutics FY24 EPS $(1.61) Up F...
03/19/2025 20:04:23

century-therapeutics-announces-preclinical-pipeline-re-prioritization-to-focus-on-four-potentially-transformative-programs-to-advance-toward-clinic-led-by-cnty-308-in-b-cell-mediated-autoimmune-diseases-and-malignancies-new-concentrated-clinical-focus-for-cnty-101-based-on-unique-profile-with-transformational-potential-in-autoimmune-disease-data-anticipated-in-2025
Century Therapeutics Announces Preclinical...
03/19/2025 20:03:37

Preclinical pipeline re-prioritization to focus on four potentially transformative programs to advance toward clinic, led by CN...

century-therapeutics-shares-halted-news-pending
Century Therapeutics Shares Halted, News P...
03/19/2025 20:02:22

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION